From Raw Materials to Finished Products: Analysis of Common Key Points in Quality Control of Molecular Diagnostic Kits

I. Basic Composition of Molecular Diagnostic Kits

Molecular diagnostic kits are generally used for qualitative or quantitative detection of nucleic acid targets in clinical samples. Common technology platforms include fluorescent PCR, reverse transcription PCR, and isothermal amplification. A complete molecular diagnostic kit typically contains nucleic acid extraction or purification components, amplification reaction solutions, enzyme mixtures, primers and probes, negative controls, positive controls, and instructions for use. Different detection items vary in component design, but the overall goal is to reduce operational steps and manual errors while ensuring reproducible results.

II. Nucleic Acid Extraction and Sample Pretreatment

Sample pretreatment is a critical step affecting detection results. Molecular diagnostic kits need to provide matching lysis and purification protocols for different sample types, such as throat swabs, blood, urine, and tissue. Common nucleic acid extraction methods include magnetic bead-based methods and spin column-based methods. Magnetic bead-based methods are more suitable for integration with automated platforms, while spin column-based methods are more commonly used in low- to medium-throughput laboratories. During development and production, extraction efficiency, nucleic acid integrity, purity, and potential residual inhibitors are generally evaluated. If samples contain large amounts of substances such as hemoglobin, bile salts, or polysaccharides, subsequent amplification efficiency may be affected. Therefore, kit instructions typically indicate applicable sample types and storage conditions.

III. Amplification System and Contamination Control Design

The design of the amplification system requires consideration of primer and probe specificity, enzyme thermostability, and buffer ion concentration, among other factors. To prevent false positives caused by amplification product contamination, many molecular diagnostic kits incorporate a uracil-DNA glycosylase system or physically separate the sample loading area, extraction area, and amplification area in the workflow. Some kits use pre-dispensed lyophilized or premixed liquid formats to reduce preparation steps and lower the risk of cross-contamination. For quality control, negative controls and positive controls are typically used to determine whether an entire batch of reagents is in a controlled state; however, specific acceptance criteria should be implemented in accordance with product instructions and the laboratory quality system.

IV. Quality Control and Stability Studies

Molecular diagnostic kits require multiple quality studies before and after market launch, commonly including accuracy, precision, analytical sensitivity, analytical specificity, and linear range. Accuracy refers to the consistency of detection results with a reference method or reference material; precision examines repeatability within the same batch and between different batches. Stability studies focus on performance maintenance under conditions such as shelf life, transportation, opened vial, and freeze-thaw. Manufacturing enterprises generally inspect each batch of products in accordance with quality system requirements to ensure that key performance indicators meet established standards.

V. Storage, Transportation, and Usage Recommendations

Most molecular diagnostic kits are temperature-sensitive, with common storage conditions being -20°C or 2–8°C protected from light; specific conditions should be followed according to the instructions. During transportation, cold chain integrity must be maintained to avoid repeated freeze-thaw cycles that could lead to decreased enzyme activity or probe degradation. Before use, reagents should be fully equilibrated to room temperature, mixed well, and briefly centrifuged. Operators should be trained and strictly follow laboratory standard operating procedures to reduce deviations caused by manual operations.

VI. Trends in Automation and Data Management

With increasing laboratory automation, molecular diagnostic kits are increasingly used in conjunction with fully automated nucleic acid extractors, PCR amplifiers, and result analysis software. Automated workflows help reduce manual pipetting errors and improve sample throughput and result consistency. Some kits are designed with barcode or LIS integration capabilities to facilitate sample tracking and report management. However, it is worth noting that automation does not equate to zero risk; routine operations still require regular equipment calibration, internal quality control, and participation in external quality assessment.